Everlab, an Australian healthtech company founded in Melbourne in 2023, has raised AU$65 million in an oversubscribed Series A funding round led by Airtree Ventures with participation from Plural, Left Lane Capital, b2venture, and angel investors including Australian Test captain Pat Cummins. This announcement marks the company's evolution into a complete care platform designed to transform a primary care system built to treat illness into one built to prevent it.
Everlab's platform integrates diagnostics, doctors, specialists, prescriptions, and continuous AI-powered care into a single digital application. The goal is to provide patients with a longitudinal view of their health for the first time, and it connects with over 1,850 health provider locations, 180 active clinicians, and more than 30 wearable devices, processing over 200,000 health reports each month. Everlab has already completed over 40,000 consultations supporting 20,000 individual patients and major corporate partners including Boston Consulting Group, BHP, and Bain & Company.
Image Credit: Everlab
What Makes This Trend Stand Out
- Preventive Care Platforms
- Integrated digital health ecosystems are shifting primary care from episodic treatment toward proactive monitoring, creating space for subscription-based prevention models.
- AI-powered Health Navigation
- Continuous analysis of diagnostics, wearables, and clinician inputs enables personalized care pathways that can reduce fragmentation across the patient journey.
- Longitudinal Health Data
- Unified patient records built from ongoing health reports and device data support earlier risk detection and more precise clinical decision-making.
Sectors Adopting This
- Healthtech
- Comprehensive care applications are expanding the role of digital health companies from point solutions into full-service healthcare infrastructure.
- Corporate Wellness
- Employer partnerships with preventive health platforms introduce data-rich benefits programs that may improve workforce health while managing long-term costs.
- Wearable Technology
- Connected devices are becoming foundational inputs for clinical platforms, increasing the value of interoperable sensors and continuous biomarker tracking.
